NO20041212L - Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav. - Google Patents

Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.

Info

Publication number
NO20041212L
NO20041212L NO20041212A NO20041212A NO20041212L NO 20041212 L NO20041212 L NO 20041212L NO 20041212 A NO20041212 A NO 20041212A NO 20041212 A NO20041212 A NO 20041212A NO 20041212 L NO20041212 L NO 20041212L
Authority
NO
Norway
Prior art keywords
preparation
growth factor
cocktail composition
autologous growth
factor cocktail
Prior art date
Application number
NO20041212A
Other languages
English (en)
Norwegian (no)
Inventor
Samuel Simon Asculai
Ming Hao Zheng
Original Assignee
Verigen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verigen Ag filed Critical Verigen Ag
Publication of NO20041212L publication Critical patent/NO20041212L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20041212A 2001-09-24 2004-03-23 Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav. NO20041212L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32445301P 2001-09-24 2001-09-24
PCT/US2002/030343 WO2003026689A1 (en) 2001-09-24 2002-09-24 Autologous growth factor cocktail composition, method of production and use

Publications (1)

Publication Number Publication Date
NO20041212L true NO20041212L (no) 2004-05-10

Family

ID=23263651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041212A NO20041212L (no) 2001-09-24 2004-03-23 Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.

Country Status (15)

Country Link
US (1) US20030144197A1 (ko)
EP (1) EP1438067A4 (ko)
JP (1) JP2005521633A (ko)
KR (1) KR20040053137A (ko)
CN (1) CN1592635A (ko)
BR (1) BR0212757A (ko)
CA (1) CA2460780A1 (ko)
HU (1) HUP0501114A2 (ko)
IL (1) IL160883A0 (ko)
MX (1) MXPA04002716A (ko)
NO (1) NO20041212L (ko)
PL (1) PL371977A1 (ko)
RU (1) RU2004112543A (ko)
WO (1) WO2003026689A1 (ko)
ZA (1) ZA200402055B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE220564T1 (de) 1997-08-14 2002-08-15 Sulzer Innotec Ag Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren
US7435260B2 (en) * 1999-08-13 2008-10-14 Ferree Bret A Use of morphogenetic proteins to treat human disc disease
US6755863B2 (en) * 1999-10-08 2004-06-29 Bret A. Ferree Rotator cuff repair using engineered tissues
EP1531855A4 (en) 2002-01-10 2009-07-22 Osteotrophin Llc TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
US20040136968A1 (en) 2002-09-27 2004-07-15 Verigen Ag Autologous cells on a support matrix for tissue repair
JP2005060307A (ja) * 2003-08-12 2005-03-10 Pirumu:Kk 骨造成剤
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
CA2641063C (en) * 2006-03-23 2017-11-28 The University Of Western Australia Tenocyte cell culturing method
WO2008031196A1 (en) * 2006-09-13 2008-03-20 Enhance Skin Products, Inc. Treatment of aged skin with autologous growth factors in a hyaluronic acid delivery system
WO2008128342A1 (en) * 2007-04-18 2008-10-30 Mcgill University Composition for enhancing bone formation
US8513193B2 (en) 2008-10-13 2013-08-20 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
KR20110086045A (ko) * 2008-10-24 2011-07-27 오스테오테크, 인코포레이티드 뼈 형성 촉진용 조성물 및 뼈 형성 촉진방법
KR101288587B1 (ko) * 2011-07-12 2013-08-22 휴먼바이오텍 주식회사 줄기세포로부터 분비된 성장 인자의 대량 분리 및 농축 방법
US20140141047A1 (en) * 2012-11-19 2014-05-22 Wisconsin Alumni Research Foundation Selection of platelet rich plasma components via mineral binding

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
CA2071912C (en) * 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
ZA923086B (en) * 1991-04-29 1993-10-28 South African Medical Research A delivery system for biologicaly active growth or morphogenetic factors and a method for preparing such delivery system
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
US5989269A (en) * 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
WO2002095399A2 (en) * 2001-03-30 2002-11-28 Verigen Ag Method for certifying chondrocytes for use in cartilage regeneration

Also Published As

Publication number Publication date
CN1592635A (zh) 2005-03-09
EP1438067A1 (en) 2004-07-21
WO2003026689A1 (en) 2003-04-03
IL160883A0 (en) 2004-08-31
KR20040053137A (ko) 2004-06-23
WO2003026689A8 (en) 2004-06-10
JP2005521633A (ja) 2005-07-21
EP1438067A4 (en) 2006-06-14
CA2460780A1 (en) 2003-04-03
PL371977A1 (en) 2005-07-11
HUP0501114A2 (en) 2007-11-28
MXPA04002716A (es) 2005-11-08
BR0212757A (pt) 2004-10-13
US20030144197A1 (en) 2003-07-31
RU2004112543A (ru) 2005-03-27
ZA200402055B (en) 2005-06-22

Similar Documents

Publication Publication Date Title
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
HK1083509A1 (en) Anti-il-6 antibodies, compositions, methods and uses
EP1463412A4 (en) COMPOSITION COMPRISING WENGUANGUO EXTRACTS, PREPARATION METHODS AND USES THEREOF
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
NO20041212L (no) Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
EE05223B1 (et) Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
GB0111566D0 (en) Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
AU2003286474A8 (en) Compositions, solutions, and methods used for transplantation
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
AU2001293948A1 (en) Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DK1307237T3 (da) Perfluoralkylholdige komplekser med polære grupper, fremgangsmåde til fremstilling og anvendelse heraf
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
ITRM20010056A0 (it) Apparecchiatura per la fermentazione di sostanze, in particolare per vinificazione.
DE60139633D1 (de) Transformierender wachstumsfaktor alpha enthaltende impfstoffzusammensetzung
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
PL352750A1 (en) Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds
AU2002245510A1 (en) Method and composition for embalming
NO20034581D0 (no) Fremgangsmåte for autolog transplantasjon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application